A study for a 30 year old man who takes Levetiracetam (an AI-powered real world drug study)

---

---

Number of reports submitted per year:

Information of the patient in this study:

• Age: 30
• Gender: male

---

Comparison with patient's specific adverse outcomes:

You can check what is more associated with an adverse outcome: a drug mix, a drug, a condition, or a population of certain gender and age. Each patient is different. It is not uncommon that the results can be inconclusive or insignificant.

By the same drug(s):

• Memory Loss:
  - among males aged 30 (±5) who take the same drug: 0.37% (17 of 4,565)
  - among people who take the same drug, regardless of gender or age: 0.94% (1,382 of 146,369)
• Short Of Breath:
  - among males aged 30 (±5) who take the same drug: 0% (0 of 4,565)
  - among people who take the same drug, regardless of gender or age: 0% (0 of 146,369)
• Agitation (state of anxiety or nervous excitement):
  - among males aged 30 (±5) who take the same drug: 1.1% (50 of 4,565)
  - among people who take the same drug, regardless of gender or age: 0.83% (1,208 of 146,369)
• Diarrhoea:
  - among males aged 30 (±5) who take the same drug: 1.05% (48 of 4,565)
  - among people who take the same drug, regardless of gender or age: 1.25% (1,825 of 146,369)
• Headache (pain in head):
  - among males aged 30 (±5) who take the same drug: 0.96% (44 of 4,565)
  - among people who take the same drug, regardless of gender or age: 1.36% (1,985 of 146,369)

By each condition:

• people who have Agitation with Epilepsy:
  - among males aged 30 (±5) who have Epilepsy: 2.62% (94 of 3,582)
  - among people who have Epilepsy, regardless of gender or age: 1.59% (1,585 of 99,803)
• people who have Diarrhoea with Epilepsy:
  - among males aged 30 (±5) who have Epilepsy: 2.54% (91 of 3,582)
  - among people who have Epilepsy, regardless of gender or age: 2.14% (2,140 of 99,803)
• people who have Headache with Epilepsy:
  - among males aged 30 (±5) who have Epilepsy: 2.32% (83 of 3,582)
  - among people who have Epilepsy, regardless of gender or age: 2.85% (2,843 of 99,803)
• people who have Memory Loss with Epilepsy:
  - among males aged 30 (±5) who have Epilepsy: 2.99% (107 of 3,582)
  - among people who have Epilepsy, regardless of gender or age: 2.26% (2,251 of 99,803)
• people who have Short Of Breath with Epilepsy:
  - among males aged 30 (±5) who have Epilepsy: 0% (0 of 3,582)
  - among people who have Epilepsy, regardless of gender or age: 0% (0 of 99,803)

By each drug (FDA data only):

• people who take Levetiracetam and have Agitation:
  - among males aged 30 (±5) who take Levetiracetam and have side effects: 2.06% (50 of 2,433)
  - among people who take Levetiracetam and have side effects, regardless of gender or age: 1.62% (1,208 of 74,772)
• people who take Levetiracetam and have Diarrhoea:
  - among males aged 30 (±5) who take Levetiracetam and have side effects: 1.97% (48 of 2,433)
  - among people who take Levetiracetam and have side effects, regardless of gender or age: 2.44% (1,825 of 74,772)
• people who take Levetiracetam and have Headache:
  - among males aged 30 (±5) who take Levetiracetam and have side effects: 1.81% (44 of 2,433)
  - among people who take Levetiracetam and have side effects, regardless of gender or age: 2.65% (1,985 of 74,772)
• people who take Levetiracetam and have Memory Loss:
  - among males aged 30 (±5) who take Levetiracetam and have side effects: 0.7% (17 of 2,433)
  - among people who take Levetiracetam and have side effects, regardless of gender or age: 1.85% (1,382 of 74,772)
• people who take Levetiracetam and have Short Of Breath:
  - among males aged 30 (±5) who take Levetiracetam and have side effects: 0% (0 of 2,433)
  - among people who take Levetiracetam and have side effects, regardless of gender or age: 0% (0 of 74,772)

Common side effects *:

1. Drug Ineffective : 458 people, 10.03%
2. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 226 people, 4.95%
3. Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down): 220 people, 4.82%
4. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 203 people, 4.45%
5. Drowsiness : 154 people, 3.37%
6. Fatigue (feeling of tiredness): 145 people, 3.18%
7. Aggression : 138 people, 3.02%
8. Headache (pain in head): 138 people, 3.02%
9. Nausea (feeling of having an urge to vomit): 134 people, 2.94%
10. Nausea And Vomiting : 132 people, 2.89%
11. Thrombocytopenia (decrease of platelets in blood): 130 people, 2.85%
12. Fever : 127 people, 2.78%
13. Dizziness : 126 people, 2.76%
14. Stress And Anxiety : 123 people, 2.69%
15. Weakness : 123 people, 2.69%
16. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 120 people, 2.63%
17. Depression : 107 people, 2.34%
18. Death : 105 people, 2.30%
19. Overdose : 93 people, 2.04%
20. Fall : 92 people, 2.02%

Common co-existing conditions *:

You may use this to check any potential undetected conditions.

1. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 233 people, 5.10%
2. Partial Seizures (seizures which affect only a part of the brain at onset): 209 people, 4.58%
3. Status Epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure): 188 people, 4.12%
4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 96 people, 2.10%
5. Pain : 81 people, 1.77%
6. Stress And Anxiety : 73 people, 1.60%
7. Depression : 71 people, 1.56%
8. High Blood Pressure : 63 people, 1.38%
9. Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 56 people, 1.23%
10. Temporal Lobe Epilepsy (a term that refers to a condition where seizures are generated in the portion of the brain called the temporal lobe): 47 people, 1.03%
11. Agitation (state of anxiety or nervous excitement): 47 people, 1.03%
12. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 42 people, 0.92%
13. Sedation : 42 people, 0.92%
14. Fever : 41 people, 0.90%
15. Hiv Infection : 40 people, 0.88%
16. Complex Partial Seizures (epileptic seizure): 39 people, 0.85%
17. Insomnia (sleeplessness): 39 people, 0.85%
18. Grand Mal Convulsion (a type of generalized seizure that affects the entire brain): 39 people, 0.85%
19. Astrocytoma (tumour of the brain that originate in a particular kind of glial-cells): 35 people, 0.77%
20. Brain Neoplasm Malignant (brain cancer tumour): 34 people, 0.74%

Common co-used drugs *:

You may use this to check any potential interacting drugs.

1. Vimpat (285 people, 6.24%)
2. Lamictal (250 people, 5.48%)
3. Lamotrigine (244 people, 5.35%)
4. Lacosamide (203 people, 4.45%)
5. Clobazam (176 people, 3.86%)
6. Clonazepam (165 people, 3.61%)
7. Carbamazepine (159 people, 3.48%)
8. Phenytoin (150 people, 3.29%)
9. Tegretol (142 people, 3.11%)
10. Valproic Acid (139 people, 3.04%)
11. Dilantin (134 people, 2.94%)
12. Midazolam (123 people, 2.69%)
13. Topiramate (119 people, 2.61%)
14. Valproate Sodium (117 people, 2.56%)
15. Perampanel (116 people, 2.54%)
16. Depakote (109 people, 2.39%)
17. Trileptal (105 people, 2.30%)
18. Diazepam (91 people, 1.99%)
19. Topamax (89 people, 1.95%)
20. Lorazepam (88 people, 1.93%)

Drug effectiveness *:

---